Kirby McInerney LLP Continues Investigation of Shareholder Claims on Behalf of GoodRx Holdings, Inc. (GDRX) InvestorsBusiness Wire • 05/27/22
GoodRx and RxVantage Announce Strategic Relationship to Streamline Communications Between Providers and ManufacturersBusiness Wire • 05/17/22
2 Growth Stocks at All-Time Lows That Could Be the Ultimate Contrarian BuysThe Motley Fool • 05/13/22
GOODRX ALERT: Bragar Eagel & Squire, P.C. Is Investigating GoodRx, Inc. on Behalf of GoodRx Stockholders and Encourages Investors to Contact the FirmBusiness Wire • 05/13/22
Kirby McInerney LLP Announces an Investigation of Shareholder Claims on Behalf of GoodRx Holdings, Inc. (GDRX) InvestorsBusiness Wire • 05/12/22
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of InvestorsBusiness Wire • 05/11/22
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of InvestorsBusiness Wire • 05/11/22
The Law Offices of Frank R. Cruz Announces Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of InvestorsBusiness Wire • 05/11/22
GoodRx Holdings, Inc. (GDRX) Beats Q1 Earnings and Revenue EstimatesZacks Investment Research • 05/10/22
GoodRx Holdings, Inc. (GDRX) CEO Doug Hirsch on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/09/22
Earnings Results: GoodRx stock tanks after company says it's unlikely to achieve 2022 outlook amid issue with grocery chainMarket Watch • 05/09/22
GoodRx Appoints Raj Beri as Chief Operating Officer, Mark Hull as Chief Product Officer and Vina Leite as Chief People OfficerBusiness Wire • 05/09/22
GoodRx Holdings, Inc. (GDRX) Earnings Expected to Grow: Should You Buy?Zacks Investment Research • 05/02/22
GoodRx to Present at the RBC Capital Markets 2022 Global Healthcare ConferenceBusiness Wire • 05/02/22
GoodRx Teams Up with AssistRx to Increase Provider Awareness of Simplified Specialty Medication and Treatment InitiationBusiness Wire • 05/02/22